One such trial is the Canadian led LA LEAST trial, which is examining 2 years of endocrine therapy in women age 50 and older whose node negative breast cancers are low risk by Prosigna score, defining expected rates for breast cancer outcomes based on data from the low risk cohort in the TAILORx and MINDACT trials, and determining the known benefit of 2 years of endocrine therapy from randomized trials
can i buy stromectol without rx Ryan Hansen January 26, 2022
